Literature DB >> 10568199

Evaluation of preoperative and intraoperative arterial stimulation and venous sampling for diagnosis and surgical resection of insulinoma.

T Aoki1, M Sakon, H Ohzato, S Kishimoto, S Oshima, T Yamada, N Higaki, S Nakamori, M Gotoh, O Ishikawa, H Ohigashi, S Imaoka, Y Hasuike, K Shibata, M Monden.   

Abstract

BACKGROUND: The precise intraoperative localization of insulinoma is essential for successful surgical treatment. In addition to various imaging modalities developed recently, arterial stimulation and venous sampling (ASVS) has also been used for tumor localization.
METHODS: Preoperative and intraoperative ASVS procedures were performed in 6 patients with insulinoma. Intraoperative ASVS was performed before and after tumor resection. Immunoreactive insulin (IRI) concentrations and the IRI ratio (IRI concentration at each time interval after calcium injection/baseline IRI concentration) were determined by the conventional or a quick IRI method.
RESULTS: The site of the tumor was identified preoperatively in all patients. The peak of the IRI ratio varied widely, but setting the cutoff value at 3.0 clearly differentiated peak IRA ratios in feeding arteries from those of nonfeeding arteries. Intraoperative ASVS showed a similar elevation of IRI levels, but the elevation disappeared after tumor resection in all but 1 patient. In 2 patients, resection of the tumor was confirmed during surgery by measuring IRI levels by the quick IRI method.
CONCLUSIONS: A combination of ASVS and conventional imaging modalities is useful for precise localization of insulinoma. Resection of the tumor can be confirmed intraoperatively by comparing IRI levels associated with preoperative and postresective ASVS.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10568199     DOI: 10.1016/s0039-6060(99)70040-1

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  10 in total

1.  Impact of variant pancreatic arterial anatomy and overlap in regional perfusion on the interpretation of selective arterial calcium stimulation with hepatic venous sampling for preoperative localization of occult insulinoma.

Authors:  Scott M Thompson; Adrian Vella; F John Service; Clive S Grant; Geoffrey B Thompson; James C Andrews
Journal:  Surgery       Date:  2015-04-11       Impact factor: 3.982

2.  Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours.

Authors:  J K Ramage; A H G Davies; J Ardill; N Bax; M Caplin; A Grossman; R Hawkins; A M McNicol; N Reed; R Sutton; R Thakker; S Aylwin; D Breen; K Britton; K Buchanan; P Corrie; A Gillams; V Lewington; D McCance; K Meeran; A Watkinson
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

3.  Neuroendocrine tumors of the pancreas: benefits of new technologies.

Authors:  A Rosiere; S Mulier; L Michel; J E Donckier
Journal:  Surg Endosc       Date:  2005-04-28       Impact factor: 4.584

4.  Laparoscopic surgery in patients with sporadic and multiple insulinomas associated with multiple endocrine neoplasia type 1.

Authors:  Laureano Fernández-Cruz; Isidro Martínez; Gleydson Cesar-Borges; Emiliano Astudillo; David Orduña; Irene Halperin; Gemma Sesmilo; Manuel Puig
Journal:  J Gastrointest Surg       Date:  2005-03       Impact factor: 3.452

Review 5.  Occult sporadic insulinoma: localization and surgical strategy.

Authors:  Bassam Abboud; Joe Boujaoude
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

6.  Neuroendocrine tumors of the pancreas.

Authors:  Y Van Nieuwenhove; S Vandaele; B Op de Beeck; G Delvaux
Journal:  Surg Endosc       Date:  2003-08-15       Impact factor: 4.584

7.  Neuroendocrine Tumors of the Pancreas.

Authors:  James M. McLoughlin; Joseph A. Kuhn; Jeffrey T. Lamont
Journal:  Curr Treat Options Gastroenterol       Date:  2004-10

8.  Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs).

Authors:  John K Ramage; A Ahmed; J Ardill; N Bax; D J Breen; M E Caplin; P Corrie; J Davar; A H Davies; V Lewington; T Meyer; J Newell-Price; G Poston; N Reed; A Rockall; W Steward; R V Thakker; C Toubanakis; J Valle; C Verbeke; A B Grossman
Journal:  Gut       Date:  2011-11-03       Impact factor: 23.059

9.  Should the Selective Arterial Secretagogue Injection Test for Insulinoma Localization Be Evaluated at 60 or 120 Seconds?

Authors:  Keijiro Ueda; Tetsuhide Ito; Ken Kawabe; Lingaku Lee; Takashi Fujiyama; Yuichi Tachibana; Masami Miki; Kohei Yasunaga; Takehiro Takaoka; Akihiro Nishie; Yoshiki Asayama; Robert T Jensen; Yoshihiro Ogawa
Journal:  Intern Med       Date:  2017-09-25       Impact factor: 1.271

10.  Rapid intraoperative insulin assay: a novel method to differentiate insulinoma from nesidioblastosis in the pediatric patient.

Authors:  Vivian E Strong; Alexander Shifrin; William B Inabnet
Journal:  Ann Surg Innov Res       Date:  2007-10-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.